Orion Oyj A Market Cap ($3.76 Billion)
Market Cap & Net Worth: Orion Oyj A (ORNAV)
Orion Oyj A market cap. Orion Oyj A (HE:ORNAV) has a market capitalization of $3.76 Billion (€3.22 Billion) as of November 6, 2026. Listed on the HE stock exchange, this Finland-based company holds position #4158 globally and #15 in its home market, demonstrating a 5.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Orion Oyj A's stock price €101.00 by its total outstanding shares 31841817 (31.84 Million). Also see Orion Oyj A (ORNAV) cash flow conversion for how efficiently the company converts equity into cash flow.
Orion Oyj A Market Cap History (2015–2026)
Orion Oyj A market cap history from 2015 to 2026. Data shows growth from $834.70 Million to $3.76 Billion (13.91% CAGR). Check Orion Oyj A stock price for real-time trading data and today's change.
Orion Oyj A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Orion Oyj A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ORNAV year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.03x
Orion Oyj A's market cap is 1.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.81x
Orion Oyj A's market cap is 4.81 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $834.70 Million | $1.02 Billion | $208.20 Million | 0.82x | 4.01x |
| 2016 | $1.16 Billion | $1.07 Billion | $249.00 Million | 1.08x | 4.66x |
| 2017 | $902.56 Million | $1.08 Billion | $226.00 Million | 0.83x | 3.99x |
| 2018 | $895.16 Million | $977.40 Million | $330.30 Million | 0.92x | 2.71x |
| 2019 | $1.27 Billion | $1.05 Billion | $200.40 Million | 1.20x | 6.31x |
| 2020 | $1.19 Billion | $1.08 Billion | $219.90 Million | 1.11x | 5.42x |
| 2021 | $1.20 Billion | $1.04 Billion | $193.80 Million | 1.15x | 6.19x |
| 2022 | $1.76 Billion | $1.34 Billion | $349.50 Million | 1.31x | 5.03x |
| 2023 | $1.40 Billion | $1.19 Billion | $216.80 Million | 1.18x | 6.47x |
| 2024 | $1.59 Billion | $1.54 Billion | $329.90 Million | 1.03x | 4.81x |
Competitor Companies of ORNAV by Market Capitalization
Companies near Orion Oyj A in the global market cap rankings as of November 6, 2026. Also see Orion Oyj A assets under control for a full breakdown of the balance sheet.
Key companies related to Orion Oyj A by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #12 globally with a market cap of $1.06 Trillion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #19 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #28 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #42 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12 | Eli Lilly and Company | NYSE:LLY | $1.06 Trillion | $1364.73 |
| #19 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #28 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $272.32 |
| #42 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $288.24 |
Market Capitalization of Orion Oyj A (2015–2026)
Market capitalization of Orion Oyj A from 2015 to today. Between 2015 and today, Orion Oyj A's market cap moved from $834.70 Million to $ 3.76 Billion, with a yearly change of 13.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €3.76 Billion | +59.56% |
| 2025 | €2.36 Billion | +48.59% |
| 2024 | €1.59 Billion | +13.14% |
| 2023 | €1.40 Billion | -20.33% |
| 2022 | €1.76 Billion | +46.77% |
| 2021 | €1.20 Billion | +0.51% |
| 2020 | €1.19 Billion | -5.73% |
| 2019 | €1.27 Billion | +41.33% |
| 2018 | €895.16 Million | -0.82% |
| 2017 | €902.56 Million | -22.29% |
| 2016 | €1.16 Billion | +39.15% |
| 2015 | €834.70 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Orion Oyj A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.76 Billion USD |
| MoneyControl | $3.76 Billion USD |
| MarketWatch | $3.76 Billion USD |
| marketcap.company | $3.76 Billion USD |
| Reuters | $3.76 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Orion Oyj A
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides pharmaceutical products, which includes Nubeqa for the treatment of prostate cancer; Entacapone, Stalevo, Comtess, and Comtan to treat Parkinson's disease; Burana for inflam… Read more